With the continuous improvement of breast cancer chemotherapy regimen, Xeloda has remarkable efficacy in treating advanced breast cancer. Breast cancer has now become one of the top killers to human health. Data has verified that Xeloda in treating advanced breast cancer can reduce 34% of tumor recurrence risk. This argument indicates that Xeloda can either as monotherapy or combined with other chemotherapy regimens to extend the survival time of patients with advanced breast cancer.